The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Characteristics of ischaemic stroke associated with COVID-19
Open accessAbstract
Characteristics of ischaemic stroke associated with COVID-19Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is associated with coagulopathy causing venous and arterial thrombosis. 1 2 Recent data from the pandemic epicentre in Wuhan, China, reported neurological complications in 36% of 214 patients with COVID-19; acute cerebrovascular disease (mainly ischaemic stroke) was more common among 88 patients with severe COVID-19 than those with nonsevere disease (5.7% vs 0.8%).3 However, the mechanisms, phenotype and optimal management of ischaemic stroke associated with COVID-19 remain uncertain.We describe the demographic, clinical, radiological and laboratory characteristics of six consecutive patients assessed between 1 st and 16 th April 2020 at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK, with acute ischaemic stroke and COVID-19 (confirmed by reverse-transcriptase PCR (RT-PCR)) (table 1).All six patients had large vessel occlusion with markedly elevated D-dimer levels (≥1000μg/L).Three patients had multiterritory infarcts, two had concurrent venous thrombosis, and, in two, ischaemic strokes occurred despite therapeutic anticoagulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple immunostaining studies reveal that ACE2 protein in the human brain is predominantly or exclusively expressed in vasculature (and specifically expressed within pericytes) (52, 53, 70), and many neurological symptoms associated with CoV-2 infection like stroke or altered consciousness are consistent with an underlying vasculopathy (71-76).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,770
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J. V., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M. M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,995
Cited by
Sorted by citations
Items 101–200 of 710
Prudencio, M., Erben, Y., Marquez, C. P., Jansen-West, K. R., Franco-Mesa, C., Heckman, M. G., White, L. J., Dunmore, J. A., Cook, C. N., Lilley, M. T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7643 · Cited by 78
Neurological involvement in SARS-CoV-2 infection: A clinical systematic review
Scoppettuolo, P., Borrelli, S., & Naeije, G. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100094 · Cited by 78
Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry
SVIN Multinational Registry and Task Force, Ramos-Araque, M. E., Siegler, J. E., Ribó, M., Requena, M., López, C., de Lera, M., Arenillas, J. F., Pérez, I. H., Gómez‐Vicente, B., et al. (2021) · BMC Neurology · doi:10.1186/s12883-021-02075-1 · Cited by 77
Endothelial Dysfunction in the Brain
Sashindranath, M., & Nandurkar, H. H. (2021) · Stroke · doi:10.1161/strokeaha.120.032711 · Cited by 81
Weßels, I., Rolles, B., Slusarenko, A. J., & Rink, L. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000738 · Cited by 81
Clough, E., Inigo, J., Chandra, D., Chaves, L., Reynolds, J. L., Aalinkeel, R., Schwartz, S. A., Khmaladze, A., & Mahajan, S. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10015-6 · Cited by 75
Cagnazzo, F., Arquizan, C., Derraz, I., Dargazanli, C., Lefèvre, P.-H., Riquelme, C., Gaillard, N., Mourand, I., Gascou, G., Bonafé, A., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10285-9 · Cited by 73
Manca, R., Marco, M. D., Ince, P. G., & Venneri, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646908 · Cited by 77
COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
Fraiman, P. H. A., Godeiro-Junior, C. D. O., Moro, E., Cavallieri, F., & Zedde, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.574694 · Cited by 78
Guo, P., Benito-Ballesteros, Á., Yeung, S. P., Liu, R., Saha, A., Curtis, L., Kaşer, M., Haggard, M. P., & Cheke, L. G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.804922 · Cited by 86
Defining causality in COVID-19 and neurological disorders
Ellul, M. A., Varatharaj, A., Nicholson, T. R., Pollak, T. A., Thomas, N., Easton, A., Zandi, M. S., Manji, H., Solomon, T., Carson, A. J., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323667 · Cited by 74
Wijeratne, T., Crewther, S. G., Sales, C., & Karimi, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.607221 · Cited by 75
COVID-19 Mechanisms in the Human Body—What We Know So Far
Kumar, A., Narayan, R. K., Prasoon, P., Kumari, C., Kaur, G., Kumar, S., Kulandhasamy, M., Sesham, K., Pareek, V., Faiq, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693938 · Cited by 76
COVID‐19: Neuroimaging Features of a Pandemic
Ladopoulos, T., Zand, R., Shahjouei, S., Chang, J. J., Motte, J., James, J. C., Katsanos, A. H., Kerro, A., Farahmand, G., Far, A. V., et al. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12819 · Cited by 71
Hingorani, K. S., Bhadola, S., & Cervantes-Arslanian, A. M. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.004 · Cited by 70
Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19)
Gold, D. M., & Galetta, S. L. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135531 · Cited by 69
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke
Martí‐Fábregas, J., Guisado‐Alonso, D., Delgado‐Mederos, R., Domeño, A. M., Prats‐Sánchez, L., Guasch‐Jiménez, M., Cardona, P., Núñez-Guillén, A., Requena, M., Rubiera, M., et al. (2021) · Stroke · doi:10.1161/strokeaha.121.034883 · Cited by 69
Neurosurgical Practice During Coronavirus Disease 2019 (COVID-19) Pandemic
Özöner, B., Güngör, A., Hasanov, T., Toktaş, Z. O., & Kılıç, T. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.05.195 · Cited by 68
Presentations and mechanisms of CNS disorders related to COVID-19
Bodro, M., Compta, Y., & Sánchez‐Valle, R. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000923 · Cited by 69
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review
Ostovan, V. R., Foroughi, R., Rostami, M., Almasi‐Dooghaee, M., Esmaili, M., Bidaki, A. A., Behzadi, Z., Farzadfard, F., Marbooti, H., Jaberi, A. R., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10450-8 · Cited by 67
Persistent psychotic symptoms following COVID-19 infection
Lim, S. T., Janaway, B., Costello, H., Trip, A., & Price, G. W. (2020) · BJPsych Open · doi:10.1192/bjo.2020.76 · Cited by 66
Kumar, A., Pareek, V., Prasoon, P., Faiq, M. A., Kumar, P., Kumari, C., & Narayan, R. K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24717 · Cited by 67
Neurological manifestations in COVID-19: A narrative review
Rahman, A., Niloofa, R., Zoysa, I. D., Cooray, A., Kariyawasam, J., & Seneviratne, S. L. (2020) · SAGE Open Medicine · doi:10.1177/2050312120957925 · Cited by 64
Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke
John, S., Kesav, P., Mifsud, V. A., Piechowski‐Jóźwiak, B., Dibu, J. R., Bayrlee, A., Elkambergy, H., Röser, F., Elhammady, M. S., Zahra, K., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6799 · Cited by 62
Neurological comorbidity and severity of COVID-19
Romagnolo, A., Balestrino, R., Imbalzano, G., Ciccone, G., Riccardini, F., Artusi, C. A., Bozzali, M., Ferrero, B., Montalenti, E., Montanaro, E., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10123-y · Cited by 60
Smorenberg, A., Peters, E. J. G., van Daele, P. L. A., Nossent, E. J., & Muller, M. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.11.024 · Cited by 63
Neurological manifestations of coronavirus disease 2019: exploring past to understand present
Desai, I., Manchanda, R., Kumar, N., Tiwari, A., & Kumar, M. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04964-8 · Cited by 62
Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
Rato, M. L., Bandeira, M., Romão, V. C., & de Sousa, D. A. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01124-z · Cited by 63
Neurobiology of COVID-19: how can the virus affect the brain?
Generoso, J. S., de Quevedo, J. L. B., Cattani, M., Lodetti, B. F., Sousa, L., Collodel, A., Díaz, A. P., & Dal‐Pizzol, F. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1488 · Cited by 65
Lavi, E., & Cong, L. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104474 · Cited by 59
SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis
Singal, C. M. S., Jaiswal, P., & Seth, P. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00251 · Cited by 59
Qi, X., Keith, K. A., & Huang, J. H. (2020) · Brain Hemorrhages · doi:10.1016/j.hest.2020.11.001 · Cited by 63
Neuro-ophthalmic manifestations of coronavirus disease 19
Tisdale, A. K., & Chwalisz, B. K. (2020) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000707 · Cited by 58
Toscano, O., Cosentino, N., Campodonico, J., Bartorelli, A. L., & Marenzi, G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.648290 · Cited by 57
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Zangbar, H. S., Gorji, A., & Ghadiri, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02149-0 · Cited by 57
Chen, A., Wang, C., Zhu, W.-L., & Chen, W. (2022) · Aging and Disease · doi:10.14336/ad.2021.0704 · Cited by 60
Marfella, R., Paolisso, P., Sardu, C., Palomba, L., D’Onofrio, N., Cesaro, A., Barbieri, M., Rizzo, M. R., Sasso, F. C., Scisciola, L., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03643-0 · Cited by 56
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Favaloro, E. J., Henry, B. M., & Lippi, G. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1728832 · Cited by 55
Clinical features of thrombosis and bleeding in COVID-19
Thomas, M. R., & Scully, M. (2022) · Blood · doi:10.1182/blood.2021012247 · Cited by 56
COVID ‐19 and the heart: An update for clinicians
Goha, A. M., Mezue, K. N., Edwards, P. A., Nunura, F., Baugh, D. S., & Madu, E. C. (2020) · Clinical Cardiology · doi:10.1002/clc.23406 · Cited by 56
Eser, H. Y., Köroğlu, Y. E., Çakmak, Ö. Ö., Keskin, Ö., Gürsoy, A., & Özdemir, Y. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.656313 · Cited by 55
Iqbal, Y., Al Abdulla, M. A., Albrahim, S., Latoo, J., Kumar, R., & Haddad, P. M. (2020) · BJPsych Open · doi:10.1192/bjo.2020.85 · Cited by 53
Neuropathogenesis of SARS-CoV-2 infection
Khan, S., & Gomes, J. (2020) · eLife · doi:10.7554/elife.59136 · Cited by 53
Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids
Ramani, A., Pranty-Weßelmann, A. I., & Gopalakrishnan, J. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.007 · Cited by 52
COVID‐19–related laboratory coagulation findings
Devreese, K. M. J. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13547 · Cited by 52
Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review
Orrù, G., Conversano, C., Malloggi, E., Francesconi, F., Ciacchini, R., & Gemignani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186688 · Cited by 78
Neurological consequences of COVID-19
Brola, W., & Wilski, M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00424-6 · Cited by 52
Stroke in Coronavirus Disease 2019: A Systematic Review
Bhatia, R., Pedapati, R., Komakula, S., Srivastava, M. V. P., Vishnubhatla, S., & Khuranac, D. (2020) · Journal of Stroke · doi:10.5853/jos.2020.02264 · Cited by 52
Russell, A. R., Hardwick, M., Jeyanantham, A., White, L. M., Deb, S., Burnside, G., Joy, H. M., Smith, C. J., Pollak, T. A., Nicholson, T. R., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab168 · Cited by 56
Self-citationRabinovitz, B., Jaywant, A., & Fridman, C. B. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1803408 · Cited by 46
Presentation of fatal stroke due to SARS‐CoV‐2 and dengue virus coinfection
Estofolete, C. F., Machado, L. F., Zini, N., Luckemeyer, G. D., Moraes, M. M., dos Santos, T. M. I. L., dos Santos, B. F., Ruiz, L. G. P., Vasilakis, N., Lobo, S. M., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26476 · Cited by 46
Etiologic Subtypes of Ischemic Stroke in SARS-CoV-2 Patients in a Cohort of New York City Hospitals
Berekashvili, K., Dmytriw, A. A., Vulkanov, V., Agarwal, S., Khaneja, A., Turkel‐Parrella, D., Liff, J. M., Farkas, J., Nandakumar, T., Zhou, T., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01004 · Cited by 47
Brain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19
Prasad, K., Alomar, S. Y., Alqahtani, S. A. M., Malik, M. Z., & Kumar, V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02266-w · Cited by 47
Escalard, S., Chalumeau, V., Escalard, C., Redjem, H., Delvoye, F., Hébert, S., Smajda, S., Cicciò, G., Désilles, J., Mazighi, M., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.031011 · Cited by 46
Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Chavda, V. K., Chaurasia, B. K., Fiorindi, A., Umana, G. E., Lu, B., & Montemurro, N. (2022) · Neurology International · doi:10.3390/neurolint14020032 · Cited by 49
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review
Venketasubramanian, N., Anderson, C. S., Ay, H., Aybek, S., Brinjikji, W., de Freitas, G. R., Brutto, Ó. H. D., Fassbender, K. C., Fujimura, M., Goldstein, L. B., et al. (2021) · Cerebrovascular Diseases · doi:10.1159/000514155 · Cited by 49
Serrano, G. E., Walker, J. E., Tremblay, C., Piras, I. S., Huentelman, M. J., Belden, C. M., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac056 · Cited by 45
Arterial thrombotic complications in COVID-19 patients
Levolger, S., Bokkers, R. P. H., Wille, J. C., Kropman, R. H. J., & de Vries, J. P. P. M. (2020) · Journal of Vascular Surgery Cases and Innovative Techniques · doi:10.1016/j.jvscit.2020.06.012 · Cited by 44
Encephalopathy in COVID-19 patients; viral, parainfectious, or both?
Umapathi, T., Quek, W. M. J., Yen, J. M., Khin, H. S. W., Mah, Y. Y., Chan, C. Y. J., Ling, L. M., & Yu, W. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100275 · Cited by 45
COVID-19 associated nervous system manifestations
Khatoon, F., Prasad, K., & Kumar, V. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.07.005 · Cited by 46
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19
Kacem, I., Gharbi, A., Harizi, C., Souissi, E., Safer, M., Nasri, A., Letaief, H., Akkari, M., Hechaichi, A., Mrabet, S., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04866-9 · Cited by 44
Khedr, E. M., Elfetoh, N. A., Daef, E., Hassan, H. M., Amin, M. T., Soliman, R. K., Attia, A. M., Zarzour, A. A., Zain, M., Hussein, A. A. R. M., et al. (2021) · Neuroepidemiology · doi:10.1159/000513647 · Cited by 44
Carlo, D. T. D., Montemurro, N., Petrella, G., Siciliano, G., Ceravolo, R., & Perrini, P. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09978-y · Cited by 45
Nasonov, E. L., Beketova, T. V., Reshetnyak, T. M., Lila, A. M., Ananieva, L., Lisitsyna, T. A., & Soloviev, S. K. (2020) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2020-353-367 · Cited by 44
Vergara, J., Skoretz, S. A., Brodsky, M. B., Miles, A., Langmore, S. E., Wallace, S., Seedat, J., Starmer, H. M., Bolton, L., Clavé, P., et al. (2020) · American Journal of Speech-Language Pathology · doi:10.1044/2020_ajslp-20-00163 · Cited by 42
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Favaloro, E. J., Henry, B. M., & Lippi, G. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1729856 · Cited by 43
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Conte, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137135 · Cited by 42
Bone marrow involvement in the non-Hodgkin's lymphomata.
Rosenberg, S. A. (1975) · Europe PMC (PubMed Central) · Cited by 42
Beyrouti, R., Best, J. G., Chandratheva, A., Perry, R. J., & Werring, D. J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10425-9 · Cited by 41
Self-citationHasbani, G. E., Taher, A. T., Jawad, A. S., & Uthman, I. W. (2020) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/1179544120978667 · Cited by 40
SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk
Green, R. J., Mayilsamy, K., McGill, A. R., Martinez, T. E., Chandran, B., Blair, L. J., Bickford, P. C., Mohapatra, S. S., & Mohapatra, S. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.09.007 · Cited by 42
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Foret, T., Dufrost, V., du Mont, L. S., Costa, P., Lefèvre, B., Lacolley, P. J., Regnault, V., Zuily, S., & Wahl, D. G. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01029-3 · Cited by 40
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis
Sullivan, B. N., & Fischer, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653694 · Cited by 40
Sarkar, M. S., Madabhavi, I., Quy, P. N., & Govindagoudar, M. B. (2021) · The Clinical Respiratory Journal · doi:10.1111/crj.13438 · Cited by 41
Bhola, S., Trisal, J., Thakur, V., Kaur, P., Kulshrestha, S., Bhatia, S. K., & Kumar, P. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05875-6 · Cited by 42
Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review
Wijeratne, T., Sales, C., Karimi, L., & Crewther, S. G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01031 · Cited by 41
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
da Costa, L. H. A., Santos, B. M., & Branco, L. G. S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173629 · Cited by 40
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
Sifat, A. E., Nozohouri, S., Villalba, H., Vaidya, B., & Abbruscato, T. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000170 · Cited by 40
COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond
Mussa, B. M., Srivastava, A., & Verberne, A. J. M. (2021) · Viruses · doi:10.3390/v13030498 · Cited by 39
Coronaviruses and Central Nervous System Manifestations
Khateb, M., Bosak, N., & Muqary, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00715 · Cited by 39
Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37
Research progress of post-acute sequelae after SARS-CoV-2 infection
Jiao, T., Huang, Y., Sun, H., & Yang, L. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06642-5 · Cited by 41
Freeman-Sanderson, A. L., Ward, E. C., Miles, A., Netto, I. D. P., Duncan, S., Inamoto, Y., McRae, J., Pillay, N., Skoretz, S. A., Walshe, M., et al. (2020) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.10.113 · Cited by 40
Harrison, S. L., Fazio‐Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2021) · Cerebrovascular Diseases · doi:10.1159/000514137 · Cited by 37
Réveret, L., Leclerc, M., Émond, V., Loiselle, A., Bourassa, P., Tremblay, C., Bennett, D. A., Hébert, S. S., & Calon, F. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01647-1 · Cited by 39
COVID-19 and management of neuroimmunological disorders
Hartung, H.-P., & Aktaş, O. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0368-9 · Cited by 36
Multiple internal border zone infarcts in a patient with COVID-19 and CADASIL
Williams, O., Mohideen, S., Sen, A., Martinovic, O., Hart, J., Brex, P., & Sztriha, L. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116980 · Cited by 36
Insights into neurological dysfunction of critically ill COVID-19 patients
Deana, C., Verriello, L., Pauletto, G., Corradi, F., Forfori, F., Cammarota, G., Bignami, E. G., Vetrugno, L., & Bove, T. (2020) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2020.09.005 · Cited by 36
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex
Trifan, G., Goldenberg, F. D., Caprio, F. Z., Biller, J., Schneck, M. J., Khaja, A. M., Terna, T., Brorson, J. R., Lazaridis, C., Bulwa, Z. B., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105314 · Cited by 37
COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers
Katz, J. M., Libman, R., WANG, J. J., Filippi, C. G., Sanelli, P. C., Zlochower, A. B., Gribko, M., Pacia, S. V., Kuzniecky, R., Najjar, S., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6920 · Cited by 36
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
Savelieff, M. G., Feldman, E. L., & Stino, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105715 · Cited by 37
Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis
Lee, K. W., Khan, A. H. K. Y., Ching, S. M., Chia, P. K., Loh, W. C., Rashid, A. M. A., Baharin, J., Mat, L. N. I., Sulaiman, W. A. W., Devaraj, N. K., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.579070 · Cited by 39
European Multicenter Study of ET-COVID-19
Cagnazzo, F., Piotin, M., Escalard, S., Maïer, B., Ribó, M., Requena, M., Pop, R., Hasiu, A., Gasparotti, R., Mardighian, D., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.031514 · Cited by 35
Savić, D., Alsheikh, T. M., Alhaj, A. K., Lazović, L., Lamya, A., Bošnjaković, P., & Yousef, W. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04510-7 · Cited by 34
Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
Alshebri, M. S., Alshouimi, R. A., Alhumidi, H. A., & Alshaya, A. I. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00589-2 · Cited by 36
Kalra, R. S., Dhanjal, J. K., Meena, A. S., Kalel, V. C., Dahiya, S., Singh, B., Dewanjee, S., & Kandimalla, R. J. L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.662786 · Cited by 36
Wallach, T. E., Raden, M., Hinkelmann, L., Brehm, M., Rabsch, D., Weidling, H., Krüger, C., Kettenmann, H., Backofen, R., & Lehnardt, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066456 · Cited by 33
John, S., Hussain, S. I., Piechowski‐Jóźwiak, B., Dibu, J. R., Kesav, P., Bayrlee, A., Elkambergy, H., John, T. L. S., Röser, F., & Mifsud, V. A. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106227 · Cited by 32
Ren, A. L., Digby, R. J., & Needham, E. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10581-y · Cited by 33
Nassir, C. M. N. C. M., Hashim, S., Wong, K. K., Halim, S. A., Idris, N. S., Jayabalan, N., Guo, D., & Mustapha, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02457-z · Cited by 34
Metadata
- Authors
- Beyrouti, R., Adams, M. E., Benjamin, L., Cohen, H., Farmer, S. F., Goh, Y. Y., Humphries, F., Jäger, H. R., Losseff, N. A., Perry, R. J., Shah, S., Simister, R. J., Turner, D., Chandratheva, A., & Werring, D. J.
- Affiliations
- University College London Hospitals NHS Foundation Trust (GB)
- University of Liverpool (GB)
- University College London (GB)
- Corresponding author
- Werring, David J
- ORCID
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2020-04-30
- Volume
- 91
- Issue
- 8
- Pages
- 889-891
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- PMC
- PMC7231545
- OpenAlex
- W3022807497
- Cited by
- 711
- References
- 5
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 32 · 2023: 40 · 2022: 117 · 2021: 253 · 2020: 250
- FWCI
- 71.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- COVID-19 pandemic, SARS-CoV-2, ischemic stroke, large vessel occlusion, D-dimer, coagulopathy, venous thrombosis, anticoagulation failure, neurological complications of COVID-19, stroke features
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Aged, 80 and over, Brain Ischemia, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Coronavirus Infections, Stroke, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review